Leukemia; Lung Cancer; Cancer; Brain Tumor; Lymphoma; Colon Cancer; Stem Cells; Pharmacology

Targeting vulnerability in B-cell development leads to novel drug combination for leukemia

Despite having an overall survival rate of 94%, B-cell acute lymphoblastic leukemia (B-ALL), the most common childhood cancer, can prove